Depressive symptoms and risk of dementia The Framingham Heart Study

被引:346
|
作者
Saczynski, J. S. [1 ,2 ]
Beiser, A. [3 ,4 ]
Seshadri, S. [4 ]
Auerbach, S. [4 ]
Wolf, P. A. [4 ]
Au, R. [4 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Geriatr Med, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Primary Care Inst, Worcester, MA 01605 USA
[3] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA USA
[4] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
关键词
ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; INCIDENT DEMENTIA; COGNITIVE DECLINE; HISTORY; VITAMIN-B-12; HOMOCYSTEINE; PERFORMANCE; FREQUENCY; PLASMA;
D O I
10.1212/WNL.0b013e3181e62138
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Depression may be associated with an increased risk for dementia, although results from population-based samples have been inconsistent. We examined the association between depressive symptoms and incident dementia over a 17-year follow-up period. Methods: In 949 Framingham original cohort participants (63.6% women, mean age = 79), depressive symptoms were assessed at baseline (1990-1994) using the 60-point Center for Epidemiologic Studies Depression Scale (CES-D). A cutpoint of >= 16 was used to define depression, which was present in 13.2% of the sample. Cox proportional hazards models adjusting for age, sex, education, homocysteine, and APOE epsilon 4 examined the association between baseline depressive symptoms and the risk of dementia and Alzheimer disease (AD). Results: During the 17-year follow-up period, 164 participants developed dementia; 136 of these cases were AD. A total of 21.6% of participants who were depressed at baseline developed dementia compared with 16.6% of those who were not depressed. Depressed participants (CES-D >= 16) had more than a 50% increased risk for dementia (hazard ratio [HR] 1.72, 95% confidence interval [CI] 1.04-2.84, p = 0.035) and AD (HR 1.76, 95% CI 1.03-3.01, p = 0.039). Results were similar when we included subjects taking antidepressant medications as depressed. For each 10-point increase on the CES-D, there was significant increase in the risk of dementia (HR 1.46, 95% CI 1.18-1.79, p < 0.001) and AD (HR 1.39, 95% CI 1.11-1.75, p = 0.005). Results were similar when we excluded persons with possible mild cognitive impairment. Conclusions: Depression is associated with an increased risk of dementia and AD in older men and women over 17 years of follow-up. Neurology (R) 2010; 75: 35-41
引用
收藏
页码:35 / 41
页数:7
相关论文
共 50 条
  • [1] Depressive symptoms and risk of stroke - The Framingham Study
    Salaycik, Kimberly J.
    Kelly-Hayes, Margaret
    Beiser, Alexa
    Nguyen, Anh-Hoa
    Brady, Stephen M.
    Kase, Carlos S.
    Wolf, Philip A.
    [J]. STROKE, 2007, 38 (01) : 16 - 21
  • [2] Depressive symptoms, coronary heart disease and mortality in the Framingham heart study
    Soteriades, ES
    Evans, JC
    Vasan, RS
    Murabito, JM
    Kelly-Hayes, M
    Wolf, PA
    Benjamin, EJ
    [J]. CIRCULATION, 2001, 104 (17) : 531 - 532
  • [3] Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study
    Wulsin, LR
    Evans, JC
    Vasan, RS
    Murabito, JM
    Kelly-Hayes, M
    Benjamin, EJ
    [J]. PSYCHOSOMATIC MEDICINE, 2005, 67 (05) : 697 - 702
  • [4] Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study
    Peloso, Gina M.
    Beiser, Alexa S.
    Satizabal, Claudia L.
    Xanthakis, Vanessa
    Vasan, Ramachandran S.
    Pase, Matthew P.
    Destefano, Anita L.
    Seshadri, Sudha
    [J]. NEUROLOGY, 2020, 95 (10) : E1341 - E1350
  • [5] Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study
    Romero, Jose R.
    Beiser, Alexa
    Himali, Jayandra J.
    Shoamanesh, Ashkan
    DeCarli, Charles
    Seshadri, Sudha
    [J]. NEUROBIOLOGY OF AGING, 2017, 54 : 94 - 99
  • [6] Platelet Function Is Associated With Dementia Risk in the Framingham Heart Study
    Ramos-Cejudo, Jaime
    Johnson, Andrew D.
    Beiser, Alexa
    Seshadri, Sudha
    Salinas, Joel
    Berger, Jeffrey S.
    Fillmore, Nathanael R.
    Do, Nhan
    Zheng, Chunlei
    Kovbasyuk, Zanetta
    Ardekani, Babak A.
    Nunzio, Pomara
    Bubu, Omonigho M.
    Parekh, Ankit
    Convit, Antonio
    Betensky, Rebecca A.
    Wisniewski, Thomas M.
    Osorio, Ricardo S.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (09):
  • [7] Cerebral microbleeds and late-life depressive symptoms in the Framingham Heart Study
    Shoamanesh, A.
    Himali, J. J.
    Beiser, A. S.
    Preis, S. R.
    DeCarli, C.
    Wolf, P. A.
    Seshadri, S.
    Romero, J. R.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 372 - 372
  • [8] Social Support, BDNF, and the Risk for Stroke and Dementia: The Framingham Heart Study
    Salinas, Joel
    Beiser, Alexa
    Himali, Jayandra J.
    Satizabal, Claudia L.
    Rosand, Jonathan
    Seshadri, Sudha
    [J]. ANNALS OF NEUROLOGY, 2015, 78 : S20 - S21
  • [9] Diet, Pace of Biological Aging, and Risk of Dementia in the Framingham Heart Study
    Thomas, Aline
    Ryan, Calen P.
    Caspi, Avshalom
    Liu, Zhonghua
    Moffitt, Terrie E.
    Sugden, Karen
    Zhou, Jiayi
    Belsky, Daniel W.
    Gu, Yian
    [J]. ANNALS OF NEUROLOGY, 2024, 95 (06) : 1069 - 1079
  • [10] Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study
    Gonzales, Mitzi M.
    Samra, Jasmeet
    O'Donnell, Adrienne
    Mackin, R. Scott
    Salinas, Joel
    Jacob, Mini E.
    Satizabal, Claudia L.
    Aparicio, Hugo J.
    Thibault, Emma G.
    Sanchez, Justin S.
    Finney, Rebecca
    Rubinstein, Zoe B.
    Mayblyum, Danielle, V
    Killiany, Ron J.
    Decarli, Charlie S.
    Johnson, Keith A.
    Beiser, Alexa S.
    Seshadri, Sudha
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 (01) : 249 - 260